Primary Care Corner with Geoffrey Modest MD: Intensive glucose control and heart disease

By: Dr. Geoffrey Modest The Lancet recently had a posthoc analysis of the ACCORD trial, finding that decreasing A1C in type 2 diabetics was associated with decreasing ischemic heart disease events (see Lancet 2014; 384: 1936–41). This was one of 3 contemporary trials of intensive vs standard control of diabetics — neither ADVANCE nor VADT studies showing benefit of intensive diabetic […]

Read More…